Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-20

Clinical Trial Update: Lurasidone Pediatric Bipolar Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for lurasidone in pediatric bipolar I depression has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lurasidone (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Bipolar I Depression | Phase 3 | Status: COMPLETED | Results posted: 2017-12-20